100 Recruiting Studies Using Dexamethasone
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Dexamethasone
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Ixazomib + Pomalidomide + Dexamethasone In MM
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma
📍 University of Alabama at Birmingham — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
📍 Kaiser Permanente - Oakland ( Site 0054) — Oakland, California
Non-small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔Opioid-Free Pain Protocol After Shoulder Arthroplasty
📍 Henry Ford Health — Detroit, Michigan
Shoulder Arthropathy
View Study & Checklist ➔A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets
📍 Stanford University School of Med /ID# 242809 — Stanford, California
Relapsed/Refractory Multiple Myeloma
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
📍 Alaska Oncology & Hematology, LLC — Anchorage, Alaska
Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast Cancer
View Study & Checklist ➔A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Recurrent Multiple Myeloma
View Study & Checklist ➔Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
📍 Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey
Colorectal Cancer
View Study & Checklist ➔Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
Castration-Resistant Prostate Carcinoma
View Study & Checklist ➔Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Adult T Acute Lymphoblastic Leukemia
View Study & Checklist ➔Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy
📍 University of Michigan Rogel Cancer Center — Ann Arbor, Michigan
Multiple Myeloma
View Study & Checklist ➔Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
📍 University of Alabama at Birmingham - Main /ID# 151405 — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Multiple Myeloma
View Study & Checklist ➔A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Multiple Myeloma
View Study & Checklist ➔Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Lymphoma
View Study & Checklist ➔Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors
📍 City of Hope Medical Center — Duarte, California
Malignant Brain Neoplasm
View Study & Checklist ➔Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
View Study & Checklist ➔A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
📍 Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Chandler, Arizona
Relapsed/Refractory Diffuse Large B-cell Lymphoma
View Study & Checklist ➔Ixazomib Maintenance Study in Patients With AL Amyloidosis
📍 Tufts Medical Center — Boston, Massachusetts
AL Amyloidosis
View Study & Checklist ➔Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
📍 GSK Investigational Site — Tucson, Arizona
Multiple Myeloma
View Study & Checklist ➔A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.
📍 Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407 — Tucson, Arizona
Multiple Myeloma
View Study & Checklist ➔Elotuzumab, Pomalidomide, & Dexamethasone (Elo-Pom-Dex) With Second Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma
📍 Colorado Blood Cancer Institute (Sarah Cannon) — Denver, Colorado
Multiple Myeloma in Relapse
View Study & Checklist ➔Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma
📍 University of California San Diego — La Jolla, California
Myeloma
View Study & Checklist ➔Dexamethasone for Symptom Burden in Advanced Cancer Patients
📍 Lyndon Baines Johnson Hospital — Houston, Texas
Solid Tumors
View Study & Checklist ➔Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Recurrent Multiple Myeloma
View Study & Checklist ➔A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma
📍 Univ of Colorado Cancer Center /ID# 167331 — Aurora, Colorado
Multiple Myeloma
View Study & Checklist ➔Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM
📍 Northern Light Eastern Maine Medical Center — Bangor, Maine
Myeloma, Multiple
View Study & Checklist ➔Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
📍 UCLA Site Number : 8400010 — Los Angeles, California
Plasma Cell Myeloma
View Study & Checklist ➔A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
📍 Weill Cornell Medicine - Multiple Myeloma Center — New York, New York
Multiple Myeloma
View Study & Checklist ➔A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
📍 Local Institution - 0046 — Mobile, Alabama
Relapsed or Refractory Multiple Myeloma
View Study & Checklist ➔Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
📍 Mayo Clinic — Phoenix, Arizona
Multiple Myeloma
View Study & Checklist ➔Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
📍 University of Alabama at Birmingham — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis
📍 Boston Medical Center — Boston, Massachusetts
AL Amyloidosis
View Study & Checklist ➔Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Myeloma
View Study & Checklist ➔Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array
📍 UCLA Medical Center — Los Angeles, California
Hearing Loss
View Study & Checklist ➔A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of CC-92480 in Combination With Standard Treatments in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM)
📍 Local Institution - 119 — Denver, Colorado
Multiple Myeloma
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
📍 University of Arkansas for Medical Sciences /ID# 243096 — Little Rock, Arkansas
Relapsed/Refractory Multiple Myeloma
View Study & Checklist ➔A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
Multiple Myeloma
View Study & Checklist ➔Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Hairy Cell Leukemia
View Study & Checklist ➔Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Mantle Cell Lymphoma
View Study & Checklist ➔Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
📍 Emory University — Atlanta, Georgia
Multiple Myeloma
View Study & Checklist ➔Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
📍 Massachusetts General Hospital — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
📍 Phoenix Children's Hospital — Phoenix, Arizona
Hemophagocytic Lymphohistiocytosis
View Study & Checklist ➔A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
📍 UCSF — San Francisco, California
Multiple Myeloma
View Study & Checklist ➔Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Advanced Malignant Neoplasm
View Study & Checklist ➔Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
📍 M D Anderson Cancer Center — Houston, Texas
Recurrent Plasma Cell Myeloma
View Study & Checklist ➔A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
📍 City of Hope — Duarte, California
Amyloidosis
View Study & Checklist ➔Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
📍 Arizona Oncology Associates, PC - HOPE — Tucson, Arizona
Multiple Myeloma
View Study & Checklist ➔Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
📍 The University of Chicago — Chicago, Illinois
Myeloma
View Study & Checklist ➔Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
📍 Mount Sinai Hospital — New York, New York
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
📍 University of Alabama Comprehensive Cancer Center — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔Isa-Pom-Dex in Elderly/Frail Subjects With RRMM
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
Multiple Myeloma
View Study & Checklist ➔SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
📍 Mohtaseb Cancer Center and Blood Disorders Site Number : 8400028 — Bullhead City, Arizona
Plasma Cell Myeloma Recurrent
View Study & Checklist ➔Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
📍 Alaska Oncology and Hematology LLC — Anchorage, Alaska
Relapsed or Refractory Multiple Myeloma
View Study & Checklist ➔Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Blastoid Variant Mantle Cell Lymphoma
View Study & Checklist ➔Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Newly Diagnosed Multiple Myeloma
View Study & Checklist ➔DARA RVD For High Risk SMM
📍 Stamford Hospital — Stamford, Connecticut
High-risk Smoldering Multiple Myeloma
View Study & Checklist ➔A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
📍 UCSF Fresno — Clovis, California
Multiple Myeloma
View Study & Checklist ➔Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Plasma Cell Myeloma
View Study & Checklist ➔Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
📍 University Of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
Multiple Myeloma
View Study & Checklist ➔Venetoclax Plus Inotuzumab for B-ALL
📍 Brigham and Women's Hospital — Boston, Massachusetts
B-cell Acute Lymphoblastic Leukemia
View Study & Checklist ➔CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
📍 Yale University — New Haven, Connecticut
Recurrent Multiple Myeloma
View Study & Checklist ➔Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
📍 University of Alabama at Birmingham — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
📍 University of California — Orange, California
AL Amyloidosis
View Study & Checklist ➔Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
📍 GSK Investigational Site — Salvador, Estado de Bahia
Multiple Myeloma
View Study & Checklist ➔Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
📍 Moffitt Cancer Center — Tampa, Florida
Smoldering Multiple Myeloma
View Study & Checklist ➔Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
📍 The University of Alabama at Birmingham — Birmingham, Alabama
Multiple Myeloma
View Study & Checklist ➔A Study of Daratumumab
📍 University of Miami Sylvester Cancer Center — Miami, Florida
Multiple Myeloma
View Study & Checklist ➔A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
📍 Children's Hospital Colorado — Aurora, Colorado
Acute Lymphoblastic Leukemia ALL
View Study & Checklist ➔Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
ISS Stage III Plasma Cell Myeloma
View Study & Checklist ➔Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma
📍 UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California
Multiple Myeloma
View Study & Checklist ➔Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
📍 University of Rochester Medical Center — Rochester, New York
Multiple Myeloma
View Study & Checklist ➔The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery
📍 St. Luke's University Health Network — Bethlehem, Pennsylvania
Hand Surgery
View Study & Checklist ➔A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
📍 University Of California San Diego — San Diego, California
Multiple Myeloma
View Study & Checklist ➔KRDI in Transplant-Eligible MM
📍 Massachusetts General Hospital — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Leukemia
View Study & Checklist ➔Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
📍 Providence Alaska Medical Center — Anchorage, Alaska
DS Stage I Multiple Myeloma
View Study & Checklist ➔Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Recurrent Multiple Myeloma
View Study & Checklist ➔Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Recurrent AL Amyloidosis
View Study & Checklist ➔Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma
📍 GSK Investigational Site — Westwood, Kansas
Multiple Myeloma
View Study & Checklist ➔A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
📍 The University of Arizona Cancer Center — Tucson, Arizona
Multiple Myeloma
View Study & Checklist ➔A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
📍 Icahn School of Medicine — New York, New York
Multiple Myeloma
View Study & Checklist ➔Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
📍 Boston Children's Hospital — Boston, Massachusetts
Acute Lymphoblastic Leukemia, Pediatric
View Study & Checklist ➔Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
📍 BCCA - Vancouver — Vancouver, British Columbia
Lymphoma, B-Cell
View Study & Checklist ➔MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Multiple Myeloma
View Study & Checklist ➔A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
📍 Hospital Aleman — Ciudad Autonoma de Buenos Aires, Buenos Aires
B-Cell Non-Hodgkin Lymphoma (B-NHL)
View Study & Checklist ➔Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma
📍 MD Anderson Cancer Center — Houston, Texas
Lymphoma
View Study & Checklist ➔Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
📍 GSK Investigational Site — Atlanta, Georgia
Multiple Myeloma
View Study & Checklist ➔Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
📍 GSK Investigational Site — Boston, Massachusetts
Multiple Myeloma
View Study & Checklist ➔A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma
📍 City of Hope — Duarte, California
Multiple Myeloma
View Study & Checklist ➔